Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Xiao Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7092-4127; OpenAlex author ID A5054669141. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 2 papers

Papers 8

  1. Muscle strength and mass as predictors of pancreatic cancer: insights from the UK biobank. Co-author DOI 10.1186/s12885-025-14766-w↗
  2. Corrigendum: The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological pr… Last author DOI 10.3389/fphar.2025.1560529↗
  3. Establishment of a Prognostic Model for Pancreatic Cancer Based on Hypoxia-Related Genes. Last author DOI 10.1177/15330338241288687↗
  4. Association of textbook outcomes with improved survival in pancreatic ductal adenocarcinoma following pancreaticoduodenectomy: a retrospective study. First author DOI 10.21037/tgh-23-112↗
  5. The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic pred… Last author DOI 10.3389/fphar.2024.1498031↗
  6. Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer. Last author DOI 10.1038/s41598-023-36413-9↗
  7. LINC00960 regulates cell proliferation and glycolysis in pancreatic cancer through the miR-326-3p/TUFT1/AKT-mTOR axis. Co-author DOI 10.1002/kjm2.12594↗
  8. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1. Co-author DOI 10.1159/000485876↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kang Fu · 2 shared papers, 2024–2025 · strength 0.61
  2. Yangdong Wu · 2 shared papers, 2023–2024 · strength 0.51
  3. Qingyan Kou · 2 shared papers, 2023–2024 · strength 0.51
  4. Qian Yu · 1 shared paper, 2025 · strength 0.27
  5. Xin Liu · 1 shared paper, 2025 · strength 0.27
  6. Haikuo Wang · 1 shared paper, 2024 · strength 0.24
  7. Heyun Zhang · 1 shared paper, 2024 · strength 0.24
  8. Hanxiang Zhan · 2 shared papers, 2017–2022 · strength 0.21
  9. Weidong Guo · 1 shared paper, 2022 · strength 0.14
  10. Shanglong Liu · 1 shared paper, 2022 · strength 0.14
  11. Bin Zhou · 1 shared paper, 2022 · strength 0.14
  12. Jingyu Cao · 1 shared paper, 2022 · strength 0.14
  13. T. T. Qu · 1 shared paper, 2022 · strength 0.14
  14. Jing‐Hao Lei · 1 shared paper, 2022 · strength 0.14
  15. Bingyuan Zhang · 1 shared paper, 2017 · strength 0.07
  16. Bin Zhou · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.